Earlier this year., India's Drugs Controller General granted permission to Pune Maharashtra-based Serum Institute of India to supply over 32,000 doses of its COVID-19 jab Covovax under the brand name Nuvaxovid to the U.S. Covovax is manufactured through technology transfer from Novavax, an American Company and is approved by the...